Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phosphodiesterase expression in human epithelial cells

L C Wright1, J Seybold, A Robichaud

  • 1Department of Thoracic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London SW3 6LY, United Kingdom.

The American Journal of Physiology
|October 1, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Female genital mutilation/cutting burden and perceptions among asylum-seeking women in Berlin, Germany: A cross-sectional study.

Journal of migration and health·2026
Same author

Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps.

Allergy·2026
Same author

Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers.

bioRxiv : the preprint server for biology·2026
Same author

Update on Non-Biological and RNA-Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper.

Allergy·2026
Same author

The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways-An EAACI Position Paper.

Allergy·2026
Same author

Reply to Correspondence: The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.

Allergy·2025

Airway epithelial cells express phosphodiesterase (PDE) enzymes, particularly PDE4. Inhibiting these enzymes reduced inflammatory secretions, suggesting PDE4 inhibitors are a potential treatment for asthma.

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Pharmacology

Background:

  • Epithelial cells are key players in airway inflammation, producing inflammatory mediators.
  • Cyclic nucleotides like cAMP and cGMP regulate inflammatory cell function.
  • Phosphodiesterase (PDE) enzymes inactivate cyclic nucleotides, presenting a therapeutic target for inflammatory diseases.

Purpose of the Study:

  • To investigate the expression and function of PDE enzymes in human airway epithelial cells.
  • To identify specific PDE isogenes present in epithelial cells.
  • To evaluate the potential of PDE inhibition as a therapeutic strategy for airway inflammation.

Main Methods:

  • Studied PDE activity in A549 cells and primary human airway epithelial cells (HAECs).

Related Experiment Videos

  • Utilized specific PDE inhibitors to characterize enzyme families.
  • Employed RT-PCR to identify PDE isogene expression.
  • Assessed the impact of PDE inhibition on cellular secretion.

    • Main Results:

    • Both A549 cells and HAECs predominantly expressed PDE4 activity, with minor PDE1, PDE3, and PDE5 activity.
    • RT-PCR confirmed the expression of HSPDE4A5, HSPDE4D3, and HSPDE7.
    • Inhibition of PDE4 and PDE3 significantly reduced inflammatory secretions from epithelial cells.

    Conclusions:

    • Epithelial cells express significant PDE4 activity.
    • PDE4 enzymes are a potential therapeutic target for managing asthmatic inflammation.
    • Inhaled PDE4 inhibitors may offer a targeted approach for controlling airway inflammation.